Guidance and Documents

Please read the full call guidance and check your project is within scope first. The full call guidance can be found here : PBIAA Translational Funding Guidance 2025
Translational Research Projects
If you intend to submit to any of the three translational funding schemes, please complete this Intention to Submit form by 5 pm on Monday 13th October 2025.
Please note all EOIs are automatically eligible to apply for the full application stage. We ask for this information to ensure we secure reviewers with relevant expertise.
If you are interested in applying for a secondment please visit our secondments page here.
You will receive confirmation via email and a grant code needed for the full application. Only candidates who submitted an intention to submit form will be considered at the full proposal stage.
The full application forms for the Impact projects are available by clicking the links below:
The deadline for full applications is 5pm on Monday 24th November 2025.
We will soon publish the date for our information webinar which will be held later in September 2025.
Proof of Market: The underpinning fundamental research must already have been completed.
Proof of Feasibility: Previous proof of market research providing you with a clear view of the market and/or clinical need for your technology needs to have been completed prior to applying.
Proof of Concept: You must consult with your university’s commercialisation or technology transfer teams to ensure you have considered any IP matters before discussing with external collaborators. We encourage you to engage early: your commercialisation or tech transfer team will need to review and sign off the IP section of the application form.
Further general guidance and MedTech innovation good practice guides can be found here: https://www.imbe.leeds.ac.uk/innovation/innovation-good-practice/
To watch the replay of our March 2025 webinar visit : PBIAA Webinar 27 March 2025
For anything else please email [email protected] and we will endeavour to assist you.
